Clinical Trial Update: Full Day and Night Closed-Loop With DiAs Platform [NA]

View source ↗

Summary

A completed clinical trial evaluated full-day and night closed-loop insulin delivery using the DiAs platform for type 1 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Snippet

Sponsor: University of Virginia | Conditions: Diabetes Mellitus, Type 1 | NA | Status: COMPLETED